SAA1在多囊卵巢综合征子宫内膜细胞外基质重塑中的作用:对妊娠丢失的提示
研究利用PCOS患者与对照的血清及人子宫内膜组织和原代人子宫内膜基质细胞,探讨SAA1在子宫内膜细胞外基质重塑中的作用及机制。结果发现PCOS患者血清SAA1浓度升高,可作为妊娠丢失的独立风险因素,子宫内膜中SAA1丰度亦增加。机制上SAA1刺激子宫内膜基质细胞合成I型胶原链(COL1A1和COL1A2),该效应可被Toll样受体2/4拮抗剂或核因子κB抑制剂消除。
要点
- PCOS患者血清SAA1浓度升高,可作为妊娠丢失的独立风险因素。
- PCOS患者子宫内膜中SAA1丰度增加。
- SAA1通过TLR2/4-NF-κB通路刺激子宫内膜基质细胞合成I型胶原。
核心结论
- PCOS患者子宫内膜局部升高的SAA1通过诱导I型胶原合成导致细胞外基质过度沉积,可能妨碍胚胎植入并增加妊娠丢失风险。
- 这些观察突显了升高的SAA1在协调子宫内膜功能障碍中的关键作用,并为改善PCOS患者生殖结局提供了潜在治疗途径。
研究设计与样本
- 利用PCOS与对照患者的血清样本研究SAA1丰度与妊娠丢失的关系。
- 使用人子宫内膜组织和原代人子宫内膜基质细胞检查SAA1在细胞外基质重塑中的作用及潜在机制。
主要发现
- PCOS患者血清SAA1浓度升高,可作为妊娠丢失的独立风险。
- PCOS患者子宫内膜中SAA1丰度增加。
- SAA1刺激子宫内膜基质细胞合成I型胶原链(COL1A1和COL1A2),提示过量SAA1可能参与子宫内膜细胞外基质重塑,导致不支持持续妊娠的环境。
- 该效应可被Toll样受体2/4拮抗剂或核因子κB抑制剂消除。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Abnormal endometrial extracellular matrix (ECM) remodeling compromises endometrial receptivity and diminishes the probability of a successful live birth. Serum amyloid A1 (SAA1), a modulator of inflammation, is elevated in the circulation of polycystic ovary syndrome (PCOS) patients and involved in ECM remodeling during tissue repair. However, the specific role of SAA1 in endometrial ECM remodeling and subsequent risk of pregnancy loss in PCOS patients remains unclear. OBJECTIVE: To examine the role and underlying mechanism of SAA1 in ECM remodeling in the endometrium of PCOS patients. DESIGN: Serum samples from PCOS and control patients were utilized to investigate the relationship between the abundance of SAA1 and pregnancy loss. Human endometrial tissues and primary human endometrial stromal cells were used to examine the role and underlying mechanism of SAA1 in ECM remodeling. RESULTS: Serum SAA1 concentration was elevated and could serve as an independent risk of pregnancy loss in PCOS patients. Increased SAA1 abundance was also observed in endometrium obtained from these patients. Further mechanistic studies showed that SAA1 stimulated collagen I chains synthesis (COL1A1 and COL1A2) in endometrial stromal cells, suggesting excessive SAA1 may contribute to endometrial ECM remodeling, resulting in a nonsupportive environment for ongoing pregnancy. This effect was abolished by either a toll-like receptor 2/4 antagonist or a nuclear factor κB inhibitor. CONCLUSION: The locally elevated levels of SAA1 in endometrium contribute to ECM overdeposition by inducing collagen I synthesis in PCOS patients, which may hamper embryo implantation and increase the risk of pregnancy loss. These observations highlight the crucial role of heightened SAA1 in orchestrating endometrial dysfunction and shed light on potential therapeutic avenues for improving reproductive outcomes in PCOS patients.
引用
- Zhu Q, Wang Y, Xu L, et al. Role of SAA1 in Endometrial Extracellular Matrix Remodeling in Polycystic Ovary Syndrome: Implication for Pregnancy Loss. J Clin Endocrinol Metab. 2025. PMID: 39210610. doi:10.1210/clinem/dgae596
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。